Ibex Investors’s Chemed CHE Stock Holding History

Ibex Investors’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,068	Closed	-$263K	–	196
2017 Q4	$263K	Buy	+1,068	New	+$243K	0.15%	75

Other funds holding CHE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ibex Investors's CHE Position: Q1 2018 in Review

Ibex Investors sold out of Chemed (CHE) in Q1 2018, closing a stake of 1,068 shares — an estimated $263K sold.

Ibex Investors first reported a position in CHE in Q4 2017 and held it in 1 quarter. The position peaked at $263K in Q4 2017. 288 funds tracked by Wall St. Rank hold CHE as of Q1 2018.

Ibex Investors reported no remaining Chemed position as of Q1 2018 after selling out during the quarter.
Ibex Investors sold 1,068 Chemed shares in Q1 2018, an estimated $263K.
Ibex Investors first reported a position in Chemed in Q4 2017 and held it in 1 quarter.
Ibex Investors's Chemed position peaked at $263K in Q4 2017.
288 funds tracked by Wall St. Rank held Chemed as of Q1 2018.

Based on Ibex Investors's 13F filing for Q1 2018, filed 15 May 2018.